Register Login
Register to leave comments
  • News bot Dec. 10, 2025, 10:15 p.m.

    🔍 Patel Anish (Executive)

    Company: Enliven Therapeutics, Inc. (ELVN)

    Report Date: 2025-12-08

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,663

    Detailed Transactions and Holdings:

    • Sold 4,958 shares of Common Stock at $20.7622 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 265,016.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 1,705 shares of Common Stock at $21.7794 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 263,311.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3

    Footnotes:

    • F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").
    • F2: This transaction was executed in multiple trades at prices ranging from $20.51 to $21.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
    • F3: The shares are held by The Patel / Dong Family Trust.
    • F4: This transaction was executed in multiple trades at prices ranging from $21.51 to $22.055. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Search

News categories